These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3144621)

  • 1. A 40-year-old patient with an evolving extensive inferior MI treated with t-PA thrombolytic therapy.
    Denke NJ
    J Emerg Nurs; 1988; 14(6):334-7. PubMed ID: 3144621
    [No Abstract]   [Full Text] [Related]  

  • 2. Recombinant tissue plasminogen activator (rt-PA): is it the thrombolytic agent of choice for an evolving acute myocardial infarction?
    Sherry S
    Am J Cardiol; 1987 Apr; 59(9):984-9. PubMed ID: 3105303
    [No Abstract]   [Full Text] [Related]  

  • 3. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction.
    GUSTO investigators
    N Engl J Med; 1993 Sep; 329(10):673-82. PubMed ID: 8204123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. t-PA therapy in acute myocardial infarction.
    Giebel RA; Pavey SS; Bryant PP
    J Emerg Nurs; 1988; 14(4):206-13. PubMed ID: 3137387
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of front-loaded recombinant tissue-type plasminogen activator, anistreplase and combination thrombolytic therapy for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 4 trial.
    Cannon CP; McCabe CH; Diver DJ; Herson S; Greene RM; Shah PK; Sequeira RF; Leya F; Kirshenbaum JM; Magorien RD
    J Am Coll Cardiol; 1994 Dec; 24(7):1602-10. PubMed ID: 7963104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TNK-tPA: a new thrombolytic for treatment of acute myocardial infarction.
    Johnson TJ
    S D J Med; 2000 May; 53(5):185-6. PubMed ID: 10835948
    [No Abstract]   [Full Text] [Related]  

  • 7. Thrombolytic therapy for myocardial infarction: the problem, the promise and the price.
    Waters DD; Wiseman A
    CMAJ; 1988 Apr; 138(7):598-601. PubMed ID: 3128395
    [No Abstract]   [Full Text] [Related]  

  • 8. Thrombolytic therapy orders and record sheets: nursing care made easier.
    Rafter RH
    J Emerg Nurs; 1988; 14(4):237-9. PubMed ID: 3137388
    [No Abstract]   [Full Text] [Related]  

  • 9. Tissue-type plasminogen activator: intracoronary applications.
    Tiefenbrunn AJ
    Cathet Cardiovasc Diagn; 1990 Feb; 19(2):108-15. PubMed ID: 2106393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The influence of lipoprotein (a) in thrombolysis with r-TPA for myocardial infarction].
    Santos Filho RD; Tranchesi Júnior B; Caramelli B; Barbosa V; Gebara O; de Albuquerque CP; Vinagre C; Maranhão R; Pileggi F
    Arq Bras Cardiol; 1991 Jul; 57(1):9-12. PubMed ID: 1823766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue plasminogen activator (t-PA).
    Madhani J; Movsowitz H; Kotler MN
    Ther Drug Monit; 1993 Dec; 15(6):546-51. PubMed ID: 8122292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rebound increase of plasminogen activator inhibitor type I after cessation of thrombolytic treatment for acute myocardial infarction is independent of type of plasminogen activator used.
    Genser N; Lechleitner P; Maier J; Dienstl F; Artner-Dworzak E; Puschendorf B; Mair J
    Clin Chem; 1998 Feb; 44(2):209-14. PubMed ID: 9474013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous recombinant tissue-type plasminogen activator (rt-PA) and urokinase (UK) in patients with evolving myocardial infarction--a multicenter double-blind, randomized trial in Japan.
    Kanemoto N; Goto Y; Hirosawa K; Kawai C; Kimata S; Yui Y; Yamamoto Y
    Jpn Circ J; 1991 Mar; 55(3):250-61. PubMed ID: 1903167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue plasminogen activator in pediatric myocardial infarction.
    Krendel S; Pollack P; Hanly J
    Ann Emerg Med; 2000 May; 35(5):502-5. PubMed ID: 10783412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical application of intravenous thrombolytic therapy in acute myocardial infarction].
    Kanmatsuse K; Kajiwara N
    Nihon Naika Gakkai Zasshi; 1992 Aug; 81(8):1213-7. PubMed ID: 1431461
    [No Abstract]   [Full Text] [Related]  

  • 16. Front-loaded infusion therapy of rT-PA during active menstruation. A case report.
    Lee DW; Garza JL
    Angiology; 1994 Apr; 45(4):311-4. PubMed ID: 8161010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serial changes in plasma concentration of plasminogen activator inhibitor-1 before and serially after thrombolytic therapy for acute myocardial infarction.
    Goto S; Kawai Y; Handa S; Abe S; Takahashi E; Watanabe K; Hori S; Ikeda Y
    Cardiology; 1993; 82(4):280-5. PubMed ID: 8402755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New developments in thrombolytic therapy.
    Collen D; Gold HK
    Adv Exp Med Biol; 1990; 281():333-54. PubMed ID: 2129372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [t-PA in thrombolytic therapy of acute myocardial infarct].
    Rutsch W; Schmutzler H
    Herz; 1994 Dec; 19(6):336-52. PubMed ID: 7843690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized placebo-controlled trial of combined early intravenous captopril and recombinant tissue-type plasminogen activator therapy in acute myocardial infarction.
    Nabel EG; Topol EJ; Galeana A; Ellis SG; Bates ER; Werns SW; Walton JA; Muller DW; Schwaiger M; Pitt B
    J Am Coll Cardiol; 1991 Feb; 17(2):467-73. PubMed ID: 1825097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.